Sanofi prostate cancer drug shows 28 percent survival

Related posts:

  1. Adding radiotherapy boosts prostate cancer survival
  2. U.S. clears Sanofi drug for cancer complication
  3. J&J’s prostate cancer drug approved in EU
  4. FDA warns of prostate cancer drug risks
  5. Zytiga creeps up on Provenge prostate-cancer drug